{"id":"NCT02652780","sponsor":"GenSight Biologics","briefTitle":"Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)","officialTitle":"Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01","primaryCompletion":"2018-01","completion":"2018-12","firstPosted":"2016-01-12","resultsPosted":"2020-01-23","lastUpdate":"2020-01-23"},"enrollment":37,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Optic, Atrophy, Hereditary, Leber"],"interventions":[{"type":"BIOLOGICAL","name":"GS010","otherNames":["Lenadogene Nolparvovec","rAAV2/2-ND4"]},{"type":"DEVICE","name":"Sham Intravitreal Injection","otherNames":[]}],"arms":[{"label":"GS010-treated Eyes","type":"EXPERIMENTAL"},{"label":"Sham-treated Eyes","type":"SHAM_COMPARATOR"}],"summary":"The goal of this clinical trial is to assess the effectiveness of GS010, a gene therapy, in improving the visual outcome in participants with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial mutation when vision loss is present for more than six months and up to one year.","primaryOutcome":{"measure":"Change From Baseline in ETDRS Visual Acuity (Quantitative Score) at Week 48","timeFrame":"Baseline and Week 48","effectByArm":[{"arm":"GS010-treated Eyes","deltaMin":-0.219,"sd":0.055},{"arm":"Sham-treated Eyes","deltaMin":-0.211,"sd":0.055}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8783"}]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["United States","France","Germany","Italy","United Kingdom"]},"refs":{"pmids":["36449262","34108929"],"seeAlso":["http://ghr.nlm.nih.gov/condition/leber-hereditary-optic-neuropathy","https://www.nlm.nih.gov/medlineplus/genesandgenetherapy.html"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":37},"commonTop":["Iridocyclitis","Punctate keratitis","Autoimmune uveitis","Keratic precipitates","Intraocular pressure increased"]}}